|
|
Tweet |
Prostate cancer ‘gene test’ hope
"We already know that CCP levels can predict survival for breast and, more recently, brain and lung cancers. It's really encouraging that this could also be applied to prostate cancer, where we desperately need a way to predict how aggressive the disease will be."
- Lead researcher Professor Jack Cuzick
Experts believe they can develop a genetic screening test that can tell doctors which men with prostate cancer need aggressive treatment.
Early trial results for Cancer Research UK suggest men with high levels of cell cycle progression (CCP) genes have the most deadly tumours.
The CCP test could potentially save men with milder forms of the disease from unnecessary treatment.